ventricular tachyarrhythmias
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ischemic and nonischemic patients with primary or secondary indication for an ICD according to the Chinese expert consensus on implantable cardioverter defibrillation therapy (2021)
Exclusion criteria
Exclusion criteria: 1: life expectancy less than 1 year 2: patients with LQTS, Brugada syndrome et al, in whom major arrhythmia is polymorphic ventricular tachycardia 3: patients inaccessibility for follow-up or those refused to sign informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ATP related success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| ATP related ventricular tachycardia accelerations or transformation;ATP related syncope/presyncope;ICD shocks;cardiovascular disease related hospitalizations, cardiovascular disease related death and all-cause death; | — |
Countries
China
Contacts
Anhui Provincial Hospital